EMAIL THIS PAGE TO A FRIEND

Biochimica et biophysica acta

Transport and accumulation of PVP-Hypericin in cancer and normal cells characterized by image correlation spectroscopy techniques.


PMID 24480461

Abstract

PVP-Hypericin (PVP: polyvinylpyrrolidone) is a potent anti-cancer photosensitizer for photodynamic diagnosis (PDD) and therapy (PDT). However, cellular targets and mechanisms involved in the cancer-selectivity of the photosensitizer are not yet fully understood. This paper gives new insights into the differential transport and localization of PVP-Hypericin in cancer and normal cells which are essential to unravel the mechanisms of action and cancer-selectivity. Temporal (TICS) and spatiotemporal (STICS) image correlation spectroscopy are used for the assessment of PVP-Hypericin diffusion and/or velocity in the case of concerted flow in human cervical epithelial HeLa and human lung carcinoma A549 cells, as well as in human primary dendritic cells (DC) and human peripheral blood mononuclear cells (PBMC). Spatiotemporal image cross-correlation spectroscopy (STICCS) based on organelle specific fluorescent labeling is employed to study the accumulation of the photosensitizer in nucleus, mitochondria, early-endosomes and lysosomes of the cells and to assess the dynamics of co-migrating molecules. Whereas STICS and TICS did not show a remarkable difference between the dynamics of PVP-Hypericin in HeLa, A549 and DC cells, a significantly different diffusion rate of the photosensitizer was measured in PBMC. STICCS detected a stationary accumulation of PVP-Hypericin within the nucleus, mitochondria, early endosomes and lysosomes of HeLa and A549 cells. However, significant flow due to the directed motion of the organelles was detected. In contrast, no accumulation in the nucleus and mitochondria of DC and PBMC could be monitored.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

1150706
Crospovidone, United States Pharmacopeia (USP) Reference Standard
Y0001053
Crospovidone, European Pharmacopoeia (EP) Reference Standard
00190585
Hypericin, primary pharmaceutical reference standard
C30H16O8
02286
Kollidon® 25
45798
Perylene, analytical standard
C20H12
48079 Perylene solution, certified reference material, 2000 μg/mL in dichloromethane
77627
Poly(vinylpolypyrrolidone), ~110 μm particle size
PVP10
Polyvinylpyrrolidone, average mol wt 10,000
P2307
Polyvinylpyrrolidone, plant cell culture tested, average mol wt 10,000
P0930
Polyvinylpyrrolidone, powder, BioXtra, suitable for mouse embryo
PVP360
Polyvinylpyrrolidone, average mol wt 360,000
P5288
Polyvinylpyrrolidone, for molecular biology, nucleic acid hybridization tested, mol wt 360,000
90268
Polyvinylpyrrolidone, K 25, tested according to Ph Eur
81420
Polyvinylpyrrolidone, K 30
81440
Polyvinylpyrrolidone, K 90
234257
Polyvinylpyrrolidone, powder, average Mw ~29,000
856568
Polyvinylpyrrolidone, powder, average Mw ~55,000
437190
Polyvinylpyrrolidone, average Mw ~1,300,000 by LS
24-3780
Polyvinylpyrrolidone, CP, Mw 10000, K 15
81430
Polyvinylpyrrolidone solution, K 60, 45% in H2O
P2472
Povidone, meets USP testing specifications
1551503
Povidone, United States Pharmacopeia (USP) Reference Standard
P2660000
Povidone, European Pharmacopoeia (EP) Reference Standard
PHR1250
Povidone, Pharmaceutical Secondary Standard; Certified Reference Material